Name
RF01-01 SERENA-3 - A randomized pre-surgical window of opportunity study assessing dose and duration of camizestrant treatment in post-menopausal women with ER-positive, HER2-negative primary cancer (China)
Date & Time
Wednesday, December 20, 2023
Speakers
Virtual Session Link